Product Information
SIROLIMUS 2 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $2.8544 per EA under NDC 67877074801. Its NADAC has been published 141 times since Oct 18, 2023.
Strength
2 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877074801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SIROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA214753On Market Since
3/13/2021
Pharmacological Classes
Price Statistics
The NADAC for SIROLIMUS 2 MG TABLET has been published 141 times since Oct 18, 2023, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8544 per EA |
|---|---|
| All-time high | $6.0804 (Aug 13, 2025) |
| All-time low | $2.8544 (Jun 17, 2026) |
| 52-week high | $6.0804 |
| 52-week low | $2.8544 |
| Median price | $4.5759 |
| Average price | $4.5481 |
| Largest weekly change | +29.7% (Dec 13, 2023) |
| Weeks tracked | 141 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SIROLIMUS 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 2 MG TABLET, manufactured by Ascend Laboratories, LLC, is $2.8544 per EA (NDC 67877074801), effective Jun 24, 2026.
How has the price of SIROLIMUS 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for SIROLIMUS 2 MG TABLET has declined 25.0%. It has been tracked across 141 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for SIROLIMUS 2 MG TABLET?
Since Oct 18, 2023, the NADAC for SIROLIMUS 2 MG TABLET has ranged from a low of $2.8544 (Jun 17, 2026) to a high of $6.0804 (Aug 13, 2025), with a median of $4.5759 per EA.
Are there cheaper alternatives to SIROLIMUS 2 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SIROLIMUS 2 MG TABLET, but none are currently priced below it.
Who manufactures SIROLIMUS 2 MG TABLET?
SIROLIMUS 2 MG TABLET (NDC 67877074801) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification